Renal impairment is often observed in acute heart failure (HF), which is an independent prognostic factor. It is important to identify high-risk patients, who need close follow-up and intensive care for renal protection. This study was conducted to identify the factors associated with the subsequent occurrence of HF-related renal dysfunction in patients, who were admitted to the hospitals due to acute HF symptoms. We evaluated 254 consecutive patients with acute HF. HF-related renal dysfunction was defi ned when highest serum creatinine level was greater than 1.2 mg/dl and the serum creatinine level increased by more than 50% compared with the baseline value during the admission. Forty patients with acute HF (16%) had subsequent renal dysfunction after admission. Elevated serum C-reactive protein (CRP) levels ( 5 mg/dl, odds ratio 2.51, p = 0.008 by univariate analysis, odds ratio 2.43, p = 0.019 by multivariate analysis) during the fi rst week after admission and over-reduction of body weight ( 4.5 kg, odds ratio 2.68, p = 0.005 by univariate analysis, odds ratio 2.53, p = 0.010 by multivariate analysis) by acute HF treatment were signifi cantly associated with this phenomenon. Patients with high CRP levels ( 5 mg/dl) during the fi rst week after admission showed a signifi cantly greater elevation of serum creatinine levels as compared to the levels before admission than those with low CRP levels (< 5 mg/dl). In conclsion, higher serum levels of CRP could predict the subsequent renal impairment in patients admitted with the worsening of HF symptoms.
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acute heart failure; renal dysfunction; C-reactive protein; infl ammation; infection symptoms and signs secondary to abnormal cardiac function. Cardiogenic shock was defi ned as clinical evidence of systemic hypoperfusion with less than 90 mmHg or the need for supportive measures to maintain systolic pressure more than 90 mmHg. We collected the data of serum creatinine levels at admission as the baseline values and defi ned patients with HF-related renal dysfunction when highest serum creatinine level during hospitalization was greater than 1.2 mg/dl and increased by more than 50% compared with the baseline values, as previously described (Fukumoto et al. 2003) . We also measured body weight of patients during their hospitalization. We defi ned the body weight reduction as the reduction from the admission to the discharge. When multiple measurements of CRP were carried out in the fi rst week of hospitalization, we regarded the highest CRP levels during the fi rst week after admission and also evaluated the CRP levels at their discharge. High CRP levels of 5 mg/dl during the fi rst week after admission, those of 0.5 mg/dl at their discharge, body weight reduction of 4.5 kg, mean blood pressure of 120 mmHg, heart rate of 100 bpm, age of 81 years old, and BNP levels of 500 pg/m were defi ned as the top 1/3 percentile of this study population.
Data collection
Baseline demographic information (including age, sex, and body weight), New York Heart Association (NYHA) classes, presence of infection as a trigger of HF, vital signs, etiologies of HF (dilated cardiomyopathy (DCM), hypertensive heart disease (HHD), ischemic heart disease (IHD), valvular heart disease (VHD), and congenital heart disease), complications of coronary risk factors (diabetes mellitus, hypertension, chronic renal failure, and history of brain infarction) were recorded for each patient. (Fonarow et al. 2005; Fonarow and Heywood 2006; Lassus et al. 2007) . Therefore, it is important to identify high-risk patients with acute HF who need close follow-up and intensive care for renal protection. Renal function may be worsened by the reduced renal blood fl ow and glomerular fi ltration rate as a consequence of low cardiac output, the renal vasoconstriction due to increased sympathetic nervous system or the activated reninangiotensin-aldosterone system, the increased peripheral vascular resistance, or over-use of loop diuretics such as furosemide (Schrier and Abraham 1999) . However, little is known about the risk factors for HF-related worsening of renal function. In the present study, we examined the relationship between clinical factors and HFrelated renal dysfunction. Recently, it has been reported that C-reactive protein (CRP) could be the predictors of readmission or mortality in patients with HF (Alonso-Martinez et al. 2002; Horwich et al. 2002) . We thus included CRP levels as a potential risk factor in this analysis.
METHODS

Study population
We retrospectively evaluated all 254 consecutive patients with acute HF caused by known cardiac structural and functional abnormalities, who admitted to Kyushu University Hospital from December 2002 to November 2003 and Aso-Iizuka Hospital from April 2004 to March 2005. There were 137 men and 117 women. We did not include patients who had acute HF due to acute coronary syndromes, those who have already taken hemodialysis, and those who died during the study. For each patient, we collected baseline demographics, clinical, procedural, and outcome data including the presence of infectious symptoms. We measured serum levels of creatinine, blood urea nitrogen (BUN), CRP, B-type natriuretic peptide (BNP), and lipid profi les during hospitalization. Serum biochemistry measurements including creatinine and CRP measurements were conducted by autoanalysis (TBA 200FR, Toshiba Medical Systems Corporation, Tokyo) with turbidimetric immunoassay.
Defi nitions
Acute heart failure was defi ned as the rapid onset of lactone), aspirin, and statin (HMG-CoA reductase inhibitor) were recorded. Death and the need of hemodialysis or ventilation support during hospitalization were also recorded.
Statistical analysis
Continuous variables were expressed as mean ± S.D. Comparisons between patients with and without HFrelated renal dysfunction were made by use of unpaired t-test for continuous variables and chi-square test for categorical variables, and logistic regression analysis for univariate and multivariate analyses to determine the independent predictors. All statistical analyses were performed using Stat View (SAS Institute, Cary, NC, USA) and Excel (Microsoft Corporation), and p values of less than 0.05 were considered statistically signifi cant.
RESULTS
HF-related renal dysfunction and CRP levels
No patient had cardiogenic shock, needed hemodialysis, and died in this study population. Baseline patients' characteristics were described in Table 1 . Forty out of 254 patients (16%) had HF-related renal impairment by the defi nition mentioned above. There were no signifi cant differences in age, sex, severity of heart failure, the etiologies, medications, baseline creatinine or BUN values, and lipid profi les between the patients with and without HF-related renal dysfunction (Table 2) . However, univariate analysis indicated that patients with HF-related renal dysfunction had a signifi cantly greater reduction in their body weight after acute HF treatment (−5.1 ± 3.3 vs −3.6 ± 3.5 kg, p < 0.01) and had significantly higher serum CRP levels during fi rst week after admission (7.5 ± 6.7 vs 4.4 ± 5.7 mg/dl, p < 0.01), but not at discharge (0.9 ± 1.2 vs 0.7 ± 1.5 mg/dl, N.S), than those without HF-related renal dysfunction did (Table 2) .
A univariate logistic regression analysis showed that both serum CRP levels of higher than 5 mg/dl and body weight reduction of greater than 4.5 kg by acute HF treatment were independent predictors of HF-related renal dysfunction (Table  3 ). There was a 2.51-fold increase in the risk of HF-related renal dysfunction in patients with high serum CRP levels (CRP 5 mg/dl) and a 2.68-fold increase in those with body weight Continuous data are shown as mean ± S.D. HF, heart failure; N, number; BP, blood pressure; EF, ejection fraction; BNP, B-type n a t r i u r e t i c p e p t i d e ; D C M , d i l a t e d cardiomyopathy; HHD, hypertensive heart disease; IHD, ischemic heart disease; VHD, valvular heart disease; Cr, creatinine; Ccr, creatinine clearance; which is calculated by Cockroft-Gault formula; BUN, blood urea n i t r o g e n ; T C , t o t a l c h o l e s t e r o l ; T G , triglyceride; LDL, low density lipoprotein; HDL, high density lipoprotein. TABLE TABLE T 3. Univariate analysis of predictors for heart failure-related renal dysfunction using logistic regression analysis. reduction ( 4.5 kg) after acute HF treatment (Table 3) . When all patients were divided into 2 groups by CRP levels of 5 mg/dl during the fi rst week after admission, patients with higher CRP levels ( 5 mg/dl) showed the signifi cantly greater elevation of serum creatinine levels as compared to the level before admission than those with lower CRP levels (< 5 mg/dl) (42.3 ± 45.2 vs 23.3 ± 26.7 mg/dl, p < 0.01).
A multiple logistic regression analysis showed that there was a 2.43-fold increase in the risk of HF-related renal dysfunction in patients with high serum CRP levels (CRP 5 mg/dl) and a 2.53-fold increase in those with body weight reduction ( 4.5 kg) after acute HF treatment (Table 4) .
DISCUSSION
Acute HF is regulated by several factors including renin-aldosterone-angiotensin system, oxidative stress, and infl ammatory responses. The present study has demonstrated that high CRP levels during the fi rst week after admission can predict renal impairment in patients with acute HF. It has been reported that many cytokines and growth factors such as interleukin-4, interleukin-6, and tumor necrosis factor alpha, and adhesion molecules are upregulated in acute heart failure in parallel with circulating CRP levels (Andreassen et al. 1998; Sato et al. 1999; Deliargyris et al. 2000; Chin et al. 2003; Peschel et al. 2003) . These infl ammatory cytokines and growth factors can cause cytotoxic/nephrotoxic and vasoconstrictive responses (Fukumoto et al. 1997; Panzer et al. 2006) , and may contribute to renal damages including apoptosis of mesangial cells and tubular injury (Duffi eld et al. 2000; Panzer et al. 2006; Zager et al. 2006) . Therefore, infl ammatory process seen in acute HF may be well recognized to induce renal impairment.
Furthermore, it also has been reported that CRP can directly decrease endothelial nitric oxide synthesis (eNOS) expression and bioactivity (Venugopal et al. 2002) and can reduce nitric oxide production (Verma et al. 2002) . Elevated levels of CRP are also related with abnormal endothelial vascular reactivity in human (Gonzalez and Selwyn 2003) , impaired acetylcholine-induced human forearm blood fl ow (Gonzalez and Selwyn 2003) , or the progression of atherosclerosis in human and animals (Fukumoto et al. 2003; Ridker and Morrow 2003; Paul et al. 2004; Williams et al. 2004 ). Thus, high CRP levels from any cause may independently induce renal impairment by the reduction of renal blood fl ow and glomerular fi ltration rate.
Body weight reduction of more than 4.5 kg is also an independent predictor of HF-related renal dysfunction, as a greater body weight reduction refl ects a greater dieuretics, which may worsen renal function in patients with acute HF (Schrier and Abraham 1999) .
Acute HF and renal dysfunction coexist in the same patient, which is called the "cardiorenal syndrome", and that renal impairment is an independent prognostic risk factor in acute HF (Fonarow et al. 2005; Fonarow and Heywood 2006; Lassus et al. 2007) . It is considered that acute HF-related renal dysfunction is caused by not only diminished renal perfusion but also increased activity of the renin-angiotensin system, oxidative stress, infl ammation, and increased activity of the sympathetic nervous system (Bongartz et al. 2005) . Further, renal dysfunction causes further congestion and neurohormonal activation, which are factors associated with adverse outcomes (Bongartz et al. 2005) . While HF and renal dysfunction stimulate neurohormonal activation, increasing both preload and afterload and reducing cardiac output, inotropic agents further augment this neurohormonal activation. While diuretics can produce hypovolemia, intravenous vasodilators can cause hypotension, both of which can diminish renal perfusion (Fonarow and Heywood 2006) . We need the delicate hemodymanic balance to manage such high-risk patients; however, few evidence-based data are available to guide management decisions (Fonarow and Heywood 2006) . Therefore, further clinical studies are required to demonstrate how to avoid the HF-related renal dysfunction.
Limitations of the study
Several limitations should be mentioned for the present study. First, this is a retrospective study with a relatively small number of patients from the two institutions. Second, the mechanisms for renal impairment in patients with acute HF remain to be elucidated. Third, it was very diffi cult to see the peak of CRP levels and the initial onset of acute heart failure. Forth, it obviously remains to be examined what treatment can prevent the acute HF-related renal dysfunction, which should be examined in future.
Clinical implications and conclusion
Infl ammation may worsen the renal function in patients with acute HF; therefore, anti-infl ammatory therapies or renal vascular dilatations might be expected to be a novel therapeutic strategy to improve the prognosis of acute HF. ANP may be a promising therapeutic agent with renal protective effects, when it is used for long periods until CRP levels decline, although this deserves further investigation.
